Cancer Biology and Pathophysiology
Cancer biology and pathophysiology is the study of how normal cells acquire the genetic and epigenetic alterations that let them grow, survive, invade, and spread without regard for the controls that govern healthy tissue. It is the basic-science foundation of medical oncology, explaining why neoplasms arise, how they progress, and how their shared biological capabilities create both vulnerabilities and therapeutic targets.
Definition
Cancer biology and pathophysiology is the field that describes neoplasia at the cellular and molecular level, treating cancer as a disease in which heritable alterations in somatic cells produce a population that proliferates, evades growth suppression and cell death, and progressively invades and disseminates.
Scope
This area orients the reader to the core processes that define malignancy: the acquired capabilities that distinguish cancer cells from their normal counterparts, the genetic and molecular drivers that initiate and sustain them, the multistep evolution from initiation to invasive disease, the supportive role of the tumor microenvironment and new blood vessels, and the cascade by which tumors metastasize. It is a conceptual map of the subordinate topics rather than an exhaustive treatment of any one; clinical management is covered elsewhere in medical oncology.
Sub-topics
Core questions
- What distinguishes a cancer cell from its normal tissue of origin?
- Which genetic and molecular changes initiate and sustain malignant growth?
- How does a tumor evolve from a single altered cell to invasive, disseminated disease?
- How do surrounding non-malignant cells and the vasculature support tumor growth?
- By what steps do cancer cells leave the primary site and colonize distant organs?
Key concepts
- Neoplasia and malignancy
- Oncogenes and tumor suppressor genes
- Driver versus passenger alterations
- Multistep carcinogenesis
- Clonal evolution and tumor heterogeneity
- Tumor microenvironment
- Angiogenesis
- Invasion and metastasis
Key theories
- Hallmarks of cancer
- A unifying framework proposing that the diverse genotypes of cancer cells converge on a small set of acquired biological capabilities — such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis — later expanded with enabling characteristics and emerging hallmarks.
- Somatic mutation and clonal evolution
- The view that cancer originates from heritable alterations in somatic cells and progresses through successive rounds of mutation and selection, producing genetically diverse subclones whose landscapes can now be read directly from tumor genomes.
Mechanisms
Malignancy emerges when somatic cells accumulate alterations that disrupt the normal balance of proliferation, differentiation, and death. Activated oncogenes and inactivated tumor suppressor genes deregulate growth-signaling and cell-cycle controls, while defects in DNA repair and genome maintenance accelerate further change. These altered cells expand under selection, generating heterogeneous clones, and recruit a supportive stroma and new blood vessels that supply nutrients and remove waste. Acquisition of invasive and migratory capabilities then allows cells to breach basement membranes, enter the circulation, and seed distant organs. The hallmark framework organizes these processes as a recurring set of acquired capabilities shared across cancer types.
Clinical relevance
Understanding cancer biology underpins how oncologists interpret tumor pathology, molecular testing, and prognosis, and it explains why therapies are directed at specific drivers or shared capabilities. This area is reference and educational in nature: it describes the biology that informs classification and research, and is not a source of individualized diagnostic or treatment recommendations.
Epidemiology
Neoplasms are among the leading causes of death worldwide and encompass hundreds of distinct diseases defined by tissue of origin and molecular features. Detailed incidence and mortality patterns are addressed within cancer epidemiology and the disease-specific entries rather than here.
History
Modern cancer biology grew from the convergence of viral oncology, somatic genetics, and molecular biology in the second half of the twentieth century, which identified oncogenes and tumor suppressor genes and framed cancer as a genetic disease of somatic cells. The hallmarks framework synthesized this understanding into a small set of shared capabilities, and large-scale genome sequencing later mapped the recurrent driver alterations across tumor types.
Key figures
- Douglas Hanahan
- Robert Weinberg
- Bert Vogelstein
- Kenneth Kinzler
Related topics
Seminal works
- hanahan-weinberg-2000
- hanahan-weinberg-2011
- vogelstein-2013
Frequently asked questions
- Is cancer one disease or many?
- Cancer is a family of hundreds of distinct diseases that differ by tissue of origin and molecular profile, yet they share a recurring set of acquired biological capabilities that define malignancy.
- What does it mean to call cancer a genetic disease?
- It means that cancers arise from heritable alterations in the DNA of somatic cells — not usually inherited from a parent — that deregulate growth, survival, and genome maintenance.